Department of Ophthalmology, ZhongShan Hospital affiliated FuDan University, School of Medicine, Shanghai, China.
Ophthalmic Plast Reconstr Surg. 2011 Jan-Feb;27(1):21-7. doi: 10.1097/IOP.0b013e3181de01a7.
To report patient outcomes after placement of porous polyethylene (PPE)/bioglass (BG) orbital implants for primary enucleation or secondary implantation.
Retrospective chart review in one surgeon's practice (J.D.N.).
A chart review of all patients who underwent placement of PPE/BG orbital implants was performed. Data included patient's age, gender, surgical indication, prior ocular surgery, medical history, procedure performed, implant size, and postoperative complications.
PPE/BG implants were placed in 170 sockets. Seventy-seven patients were women, and 85 were men. One hundred forty patients underwent primary enucleation and placement of an implant, and 22 patients underwent secondary implantation. One hundred sixty-one patients did well after orbital implantation with a comfortable socket, quiet conjunctiva, and motility. Complications occurred in 9 patients (5.3%). Excessive discharge alone occurred in 2 patients (1.2%). Seven sockets undergoing primary enucleation and implant placement had implant exposure. One patient had an early exposure, and 6 had late exposures. All exposures were successfully treated with antibiotics or additional surgery. Secondary surgeries were required by some patients, but not due to implant complications, included ectropion repair in 5 patients (2.9%) and volume augmentation in 3 patients (1.7%).
The PPE/BG orbital implant may be a useful implant for orbital reconstruction after primary enucleation or as a secondary implant.
报告多孔聚乙烯(PPE)/生物玻璃(BG)眼眶植入物用于初次眼内容剜除或二次植入后的患者结局。
一位外科医生(J.D.N.)的回顾性病例分析。
对所有接受 PPE/BG 眼眶植入物植入的患者进行了病历回顾。数据包括患者的年龄、性别、手术指征、既往眼部手术史、病史、手术过程、植入物大小和术后并发症。
PPE/BG 植入物共植入 170 个眼眶。77 名患者为女性,85 名患者为男性。140 名患者接受了初次眼内容剜除和植入物植入,22 名患者接受了二次植入。161 名患者眼眶植入后恢复良好,眼眶舒适,结膜安静,运动正常。9 名患者(5.3%)出现并发症。仅 2 名患者(1.2%)出现分泌物过多。7 个接受初次眼内容剜除和植入物植入的眼眶出现植入物暴露。1 名患者早期暴露,6 名患者晚期暴露。所有暴露均通过抗生素或进一步手术成功治疗。一些患者需要进行二次手术,但并非由于植入物并发症引起,包括 5 名患者(2.9%)的眼睑外翻修复和 3 名患者(1.7%)的容量填充。
PPE/BG 眼眶植入物可作为初次眼内容剜除或二次植入后的一种有用的眼眶重建植入物。